Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Heterocyclic carbon compounds containing a hetero ring...
Patent
1995-07-27
1999-12-28
Shah, Mukund J.
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Heterocyclic carbon compounds containing a hetero ring...
540145, 540472, 540474, 424 9362, 534 15, C07D48722, A61K 3140
Patent
active
060082119
ABSTRACT:
A broad class of photosensitive compounds having enhanced in vivo target tissue selectivity and versatility in photodynamic therapy. Many furocoumarin compounds, such as psoralens, exhibit cytostatic activity when photoactivated but exhibit little in vivo specificity for selectively accumulating in any particular target tissue such as atheromatous plaques. Reactive Oxygen Producing Photosensitizers ("ROPPs") are photoactivatable compounds having an affinity for hyperproliferating cells (such as atheromatous plaque cells), which when photoactivated, produce cytotoxic reaction products. The photoactivity of a ROPP, such as a porphyrin, may be reduced by metalating the porphyrin while the selective affinity of the metalized ROPP for hyperproliferating tissue remains substantially unchanged. By linking a furocoumarin compound to a ROPP to form a F-ROPP, the cytostatic properties of the furocoumarin portion of the F-ROPP can be exploited while the selective affinity of the ROPP portion of the compound for hyperproliferating cells such as atheromatous plaque provides enhanced tissue selectivity without cytotoxicity. In vivo, certain F-ROPPs may be forced to selectively accumulate in a target tissue by illuminating only the target tissue with light having a wavelength operable for photoactivating the F portion of the F-ROPP thereby causing the F-ROPP to either form a monoadduct with or crosslink the cellular DNA in the target tissue. Light of a second wavelength can then be delivered to the target tissue to photoactivate the ROPP portion causing further interference with cellular activity.
REFERENCES:
patent: 5109129 (1992-04-01), Morgan et al.
patent: 5116864 (1992-05-01), March et al.
patent: 5250668 (1993-10-01), Morgan et al.
Morgan et al. J. Org. Chem., 1986, 51, 1347-50.
Morgan Alan R.
Narciso, Jr. Hugh L.
Robinson Byron
PDT Pharmaceuticals, Inc.
Petit Michael G.
Shah Mukund J.
Sripada Pavanaram K.
LandOfFree
Photoactivatable compounds comprising benzochlorin and furocouma does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Photoactivatable compounds comprising benzochlorin and furocouma, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Photoactivatable compounds comprising benzochlorin and furocouma will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-2382525